통합검색
내가 찾은 검색어
'Checkpoint inhibitors' 에 대한 통합검색결과 163건입니다.
한빛사163건
-
Inorganic nanoparticle-based cancer immunotheranostics
- Coord. Chem. Rev. Available online 4 June 2025 | https://doi.org/10.1016/j.ccr.2025.216848
- 2025.06
- 바이오·의료융합
-
Photoimmuno-Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint I
- Adv. Healthc. Mater. May 21 2025, | https://doi.org/10.1002/adhm.202500880
- 2025.05
- 바이오·의료융합
-
Liquid biopsy for cancer immunotherapy: Biomarkers to predict and monitor response upon immune checkpoint blockade
- Coord. Chem. Rev. Available online 5 May 2025 | https://doi.org/10.1016/j.ccr.2025.216767
- 2025.05
- 바이오·의료융합
-
Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC
- J. Immunother. Cancer May 22 2025, 13 (5) e011636 | https://doi.org/10.1136/jitc-2025-011636
- 2025.05
- 생명과학
-
Deep Gaussian process with uncertainty estimation for microsatellite instability and immunotherapy response prediction from histology
- npj Digit. Med. May 19 2025, 8 (1) | https://doi.org/10.1038/s41746-025-01580-8
- 2025.05
- 의약학
-
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression i
- Cancer Commun. May 22 2025, | https://doi.org/10.1002/cac2.70020
- 2025.05
- 의약학
-
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
- J. Cachexia Sarcopenia Muscle Apr 2025, 16 (2) | https://doi.org/10.1002/jcsm.13758
- 2025.04
- 바이오·의료융합
-
Dendrimer Conjugates with PD-L1-Binding Peptides Enhance In Vivo Antitumor Immune Response
- Adv. Healthc. Mater. Apr 17 2025, | https://doi.org/10.1002/adhm.202500551
- 2025.04
- 의약학
-
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clin
- Clin. Cancer Res. Mar 05 2025, | https://doi.org/10.1158/1078-0432.CCR-24-3753
- 2025.03
- 의약학
-
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
- J. Immunother. Cancer Mar 06 2025, 13 (3) e010612 | https://doi.org/10.1136/jitc-2024-010612
- 2025.03
- 의약학
-
Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment
- J. Immunother. Cancer Mar 21 2025, 13 (3) e010272 | https://doi.org/10.1136/jitc-2024-010272
- 2025.03
- 의약학
-
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
- J. Hepatol. Mar 26 2025, S0168-8278(25)00207-7 | https://doi.org/10.1016/j.jhep.2025.03.019
- 2025.03
- 의약학
-
Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor
- J. Control. Release Available online 24 February 2025 | https://doi.org/10.1016/j.jconrel.2025.02.072
- 2025.02
- 바이오·의료융합
-
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4
- EMBO J. 13 February 2025 | https://doi.org/10.1038/s44318-024-00330-y
- 2025.02
-
Dual-delivery of exosome inhibitor and immune-activating gene via lipid nano-assemblies for tumor immune evasion inhibition
- J. Control. Release Feb 22 2025, S0168-3659(25)00178-6 | https://doi.org/10.1016/j.jconrel.2025.02.065
- 2025.02
- 생명과학
-
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
- Nat. Med. Jan 06 2025, | https://doi.org/10.1038/s41591-024-03398-5
- 2025.01
- 의약학
-
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
- Nat. Rev. Clin. Oncol. Jan 06 2025, | https://doi.org/10.1038/s41571-024-00979-8
- 2025.01
-
Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunothera
- J. Immunother. Cancer Dec 22 2024, 12 (12) e009541 | https://doi.org/10.1136/jitc-2024-009541
- 2024.12
- 바이오·의료융합
-
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer
- Nature Dec 04 2024, | https://doi.org/10.1038/s41586-024-08290-3
- 2024.12
- 생명과학
-
Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
- Nano Converg. Dec 13 2024, 11 (1) | https://doi.org/10.1186/s40580-024-00466-x
- 2024.12
- 바이오·의료융합
